ArticleBioengineered2022

Novel dual glucagon-like peptide-1/ glucose-dependent insulinotropic polypeptide receptor agonist attenuates diabetes and myocardial injury through inhibiting hyperglycemia, inflammation and oxidative stress in rodent animals.

Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.